Copy to clipboard 
LimaCorporate announced that Massimo Calafiore has been appointed by the Board of Directors as its new Chief Executive Officer. Emmanuel Bonhomme, who led the organization during the last five months as interim CEO following the departure of Luigi Ferrari, will take on the newly-created role of Chief Commercial Officer.
Mr. Calafiore previously served as Executive Vice President and Chief Commercial Officer of NuVasive. Before that, he was responsible for that company’s Product Marketing and Commercial Functions, as well as the NuVasive Specialized Orthopedics and NuVasive Clinical Services business units. With more than 20 years of experience in the orthopedic field and extensive knowledge of the global orthopedic markets, he will lead LimaCorporate’s continued investment in innovation and business growth.
Earlier this month, Lima reported 2Q22 orthopedic sales of $65.5 million, +14.4% compared to 2Q21. The company expects to sustain growth through the rest of the year across its regions due to a sizeable procedure backlog. LimaCorporate operates in the joint replacement and trauma market segments.
Emmanuel Bonhomme said, “It has been a pleasure and an honor to lead LimaCorporate during the last five months as interim CEO and I am very excited to carry on serving our surgeons around the world in my new role. I welcome Massimo as our new CEO and I am committed to supporting him and the Company to continue to enhance LimaCorporate’s position in the industry, offering the best and most advanced solutions for our surgeons and patients.”
Massimo Calafiore added, “I am honored to take on this role as CEO of LimaCorporate. Thanks to our internal talent, know-how, and industry-leading R&D capabilities, I will continue to focus on positioning the company as a global leader in advanced orthopedic solutions. I look forwards to working closely with all the employees and the Leadership Team to continue to serve our surgeons and patients around the globe, as we transform orthopedics, advance patient care, and most importantly, restore the eMotion of Motion in all of our patients.”
Source: LimaCorporate
LimaCorporate announced that Massimo Calafiore has been appointed by the Board of Directors as its new Chief Executive Officer. Emmanuel Bonhomme, who led the organization during the last five months as interim CEO following the departure of Luigi Ferrari, will take on the newly-created role of Chief Commercial Officer.
Mr. Calafiore...
LimaCorporate announced that Massimo Calafiore has been appointed by the Board of Directors as its new Chief Executive Officer. Emmanuel Bonhomme, who led the organization during the last five months as interim CEO following the departure of Luigi Ferrari, will take on the newly-created role of Chief Commercial Officer.
Mr. Calafiore previously served as Executive Vice President and Chief Commercial Officer of NuVasive. Before that, he was responsible for that company’s Product Marketing and Commercial Functions, as well as the NuVasive Specialized Orthopedics and NuVasive Clinical Services business units. With more than 20 years of experience in the orthopedic field and extensive knowledge of the global orthopedic markets, he will lead LimaCorporate’s continued investment in innovation and business growth.
Earlier this month, Lima reported 2Q22 orthopedic sales of $65.5 million, +14.4% compared to 2Q21. The company expects to sustain growth through the rest of the year across its regions due to a sizeable procedure backlog. LimaCorporate operates in the joint replacement and trauma market segments.
Emmanuel Bonhomme said, “It has been a pleasure and an honor to lead LimaCorporate during the last five months as interim CEO and I am very excited to carry on serving our surgeons around the world in my new role. I welcome Massimo as our new CEO and I am committed to supporting him and the Company to continue to enhance LimaCorporate’s position in the industry, offering the best and most advanced solutions for our surgeons and patients.”
Massimo Calafiore added, “I am honored to take on this role as CEO of LimaCorporate. Thanks to our internal talent, know-how, and industry-leading R&D capabilities, I will continue to focus on positioning the company as a global leader in advanced orthopedic solutions. I look forwards to working closely with all the employees and the Leadership Team to continue to serve our surgeons and patients around the globe, as we transform orthopedics, advance patient care, and most importantly, restore the eMotion of Motion in all of our patients.”
Source: LimaCorporate
You’ve reached your limit.
We’re glad you’re finding value in our content — and we’d love for you to keep going.
Subscribe now for unlimited access to orthopedic business intelligence.
JV
Julie Vetalice is ORTHOWORLD's Editorial Assistant. She has covered the orthopedic industry for over 20 years, having joined the company in 1999.
